In 2016 Sara obtained her BSc(Hons) in Medical and Pharmaceutical Biotechnology at the IMC University of Applied Sciences Krems, Austria. Before starting her PhD Sara worked as a visiting research associate at the Centre for Cancer Research and Cell Biology at Queen's University Belfast. There she researched the biological effect of Pacritinib and Azacytidine in a molecular level in myelodysplastic syndromes and acute myeloid leukaemia. Sara started her PhD later in 2016 as a Marie Curie Early Stage Researcher at the University of Glasgow. The aim of her PhD is to investigate the relationship of intracellular calcium and the mechanisms that lead to abnormal electrophysiology in rabbit atrial cardiomyocytes and intact atria when normal calcium handling is disrupted. A special focus of her PhD is the SK channel which has been suggested to mediate abnormalities in heart failure and atrial fibrillation.